Ak. Vaaler et al., OBSTRUCTIVE ATELECTASIS IN PATIENTS WITH SMALL-CELL LUNG-CANCER - INCIDENCE AND RESPONSE TO TREATMENT, Chest, 111(1), 1997, pp. 115-120
Study objectives: Define the incidence of obstructive atelectasis in p
atients presenting with small cell lung cancer and their response to t
reatment, Design: Retrospective review of clinical records and radiogr
aphic studies. Setting: Single federal government institution-the Nati
onal Cancer Institute-Naval Medical Oncology Branch. Patients: One hun
dred seventy-two consecutive patients treated between 1983 and 1993. I
nterventions: Patients presenting with obstructive atelectasis were id
entified, The incidence of dyspnea, cough, and sputum production befor
e starting treatment and 1, 3, and 6 months later was determined. Fibe
roptic bronchoscopy and chest radiographs performed before starting tr
eatment were compared with those obtained later in the patients' clini
cal course. Measurements ana results: Thirty-seven of 172 (22%) patien
ts had obstructive atelectasis, Initial symptoms included cough in 25
(68%), dyspnea in 24 (65%), and productive cough in 10 (27%), The pati
ents' symptoms of cough, dyspnea, and sputum production decreased to o
ne third of the initial prevalence 1 month after the start of treatmen
t. Fiberoptic bronchoscopy and chest radiographs performed 3 months af
ter starting treatment demonstrated bronchial patency in 90%. Conclusi
ons. Obstructive atelectasis occurs in approximately one fifth of pati
ents presenting with small cell lung cancer. Chemotherapy and chemothe
rapy plus chest radiotherapy lead to symptomatic, bronchoscopic, and r
adiographic resolution in similar proportions of patients with obstruc
tive atelectasis.